Get the Stockscreener App
206.97
0.38%
0.79
After Hours:
207.01
0.04
+0.02%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $206.97, with a volume of 2.08M.
It is up +0.38% in the last 24 hours and up +32.33% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$206.18
Open:
$207.05
24h Volume:
2.08M
Relative Volume:
0.86
Market Cap:
$87.33B
Revenue:
$234.31B
Net Income/Loss:
$1.61B
P/E Ratio:
31.24
EPS:
6.6243
Net Cash Flow:
$4.45B
1W Performance:
+1.05%
1M Performance:
+32.33%
6M Performance:
+34.18%
1Y Performance:
+72.43%
1-Day Range:
$203.84
$207.76
1-Week Range:
$201.59
$208.32
52-Week Range:
$114.60
$208.32
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
206.97 | 48.99B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
860.75 | 105.56B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
361.64 | 70.77B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
71.20 | 8.39B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5667 | 752.41M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
6 Healthcare Stocks With Strong Upward Momentum - Benzinga
Cardinal Health Stock (CAH) Opinions on Recent Stock High and Market Expansion - Quiver Quantitative
Deutsche Bank Raises Price Target on Cardinal Health to $208 From $195, Keeps Hold Rating - MarketScreener
Cardinal Health Inc. (CAH) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Can Cardinal Health Inc. stock sustain institutional flows2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com
Leerink Partners Adjusts PT on Cardinal Health to $230 From $211, Maintains Outperform Rating - MarketScreener
Can Cardinal Health Inc. (CLH) stock sustain double digit ROEStock Surge & Weekly High Return Stock Opportunities - newser.com
Tools to monitor Cardinal Health Inc. recovery probabilitySell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Cardinal Health Inc. (CLH) stock expanding market penetrationJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Understanding Cardinal Health Inc.’s price movementQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com
Can Cardinal Health Inc. stock hit consensus price targetsInsider Selling & Reliable Breakout Stock Forecasts - newser.com
Trend analysis for Cardinal Health Inc. this weekJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Is Cardinal Health Inc. stock testing key supportSell Signal & Safe Entry Trade Reports - newser.com
Why millennials buy Cardinal Health Inc. (CLH) stockLong Setup & Weekly Top Gainers Alerts - newser.com
Why Cardinal Health Inc. (CLH) stock could be next leader - newser.com
Will Cardinal Health Inc. (CLH) stock outperform Dow Jones2025 Earnings Impact & Community Driven Trade Alerts - newser.com
Is Cardinal Health Inc. stock a top dividend aristocrat candidate2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will Cardinal Health Inc. stock see PE expansionInsider Buying & Weekly Stock Performance Updates - newser.com
Will Cardinal Health Inc. stock maintain strong growthJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
Strategies to average down on Cardinal Health Inc.Portfolio Risk Report & Weekly Chart Analysis and Guides - newser.com
Will Cardinal Health Inc. stock outperform benchmarks2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
How Cardinal Health Inc. (CLH) stock trades under stagflationMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
Using R and stats models for Cardinal Health Inc. forecastingQuarterly Trade Review & Reliable Breakout Forecasts - newser.com
Can Cardinal Health Inc. recover in the next quarterWeekly Stock Report & Low Volatility Stock Recommendations - newser.com
Does Cardinal Health Inc. show high probability of reboundJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
Real time social sentiment graph for Cardinal Health Inc.July 2025 Institutional & Intraday High Probability Alerts - newser.com
There's Been No Shortage Of Growth Recently For Cardinal Health's (NYSE:CAH) Returns On Capital - Yahoo Finance
CAH (Cardinal Health) Total Operating Expense : $6,060 Mil (TTM As of Sep. 2025) - GuruFocus
Day 5 of Gains Streak for Cardinal Health Stock with 8% Return (vs. 76% YTD) [11/10/2025] - Trefis
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice - Yahoo Finance
How Cardinal Health Inc. stock valuation compares with sectorJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
When is the best time to exit Cardinal Health Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Cardinal Health Shares Sink on Mixed Results, $1.9 Billion Solaris Health Deal - MSN
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
14.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):